Patents by Inventor Meha Chhaya

Meha Chhaya has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-amyloid beta antibodies and methods of using the same
    Patent number: 11802149
    Abstract: The present inventive concept is related to antibodies, such as recombinant humanized and monoclonal antibodies, methods of making antibodies, and methods of using antibodies, such as antibodies directed toward and capable of specifically binding to and clearing amyloid-beta (A?) plaques in the brain that are suitable for use in the treatment of disorders such as Alzheimer's Disease (AD).
    Type: Grant
    Filed: October 28, 2022
    Date of Patent: October 31, 2023
    Assignee: AbbVie Inc.
    Inventors: Fan Liao, Meha Chhaya, Andrew J. McCluskey, Nathan J. Brown
  • ANTI-AMYLOID BETA ANTIBODIES AND METHODS OF USING THE SAME
    Publication number: 20230203143
    Abstract: The present inventive concept is related to antibodies, such as recombinant humanized and monoclonal antibodies, methods of making antibodies, and methods of using antibodies, such as antibodies directed toward and capable of specifically binding to and clearing amyloid-beta (A?) plaques in the brain that are suitable for use in the treatment of disorders such as Alzheimer's Disease (AD).
    Type: Application
    Filed: October 28, 2022
    Publication date: June 29, 2023
    Inventors: Fan Liao, Meha Chhaya, Andrew J. McCluskey, Nathan J. Brown
  • ANTI-NGF ANTIBODIES AND THEIR USE
    Publication number: 20180362629
    Abstract: The present disclosure encompasses NGF binding proteins, specifically to antibodies that are chimeric, CDR grafted and caninized antibodies, and methods of making and uses thereof. The antibodies, or antibody portions, of the disclosure are useful for detecting NGF and for inhibiting NGF activity, e.g., in a mammal subject suffering from a disorder in which NGF activity is detrimental.
    Type: Application
    Filed: August 31, 2018
    Publication date: December 20, 2018
    Inventors: Susan E. Lacy, Jeffrey A. Barbon, Meha Chhaya, Emma Fung, Charles W. Hutchins, Diane M. Lang, Eve H. Barlow, Mary Leddy, Ravi Chari
  • Caninized anti-NGF antibodies and their use
    Patent number: 10125192
    Abstract: The present disclosure encompasses NGF binding proteins, specifically to antibodies that are chimeric, CDR grafted and canonized antibodies, and methods of making and uses thereof. The antibodies, or antibody portions, of the disclosure are useful for detecting NGF and for inhibiting NGF activity, e.g., in a mammal subject suffering from a disorder in which NGF activity is detrimental.
    Type: Grant
    Filed: July 13, 2015
    Date of Patent: November 13, 2018
    Assignee: ZOETIS BELGIUM S.A.
    Inventors: Susan E. Lacy, Jeffrey A. Barbon, Meha Chhaya, Emma Fung, Charles W. Hutchins, Diane M. Lang, Eve H. Barlow, Mary Leddy, Ravi Chari
  • Anti-NGF antibodies and their use
    Patent number: 10093725
    Abstract: The present disclosure encompasses NGF binding proteins, specifically to antibodies that are chimeric, CDR grafted and canonized antibodies, and methods of making and uses thereof. The antibodies, or antibody portions, of the disclosure are useful for detecting NGF and for inhibiting NGF activity, e.g., in a mammal subject suffering from a disorder in which NGF activity is detrimental.
    Type: Grant
    Filed: July 14, 2015
    Date of Patent: October 9, 2018
    Assignee: ZOETIS BELGIUM S.A.
    Inventors: Susan E. Lacy, Jeffrey A. Barbon, Meha Chhaya, Emma Fung, Charles W. Hutchins, Diane M. Lang, Eve H. Barlow, Mary Leddy, Ravi Chari
  • IL-1 binding proteins
    Patent number: 9670276
    Abstract: The disclosure provides binding proteins that specifically bind to IL-1? and IL-1?. These binding proteins can be organized into DVD-Igs. These proteins can be used to modulate the activity of IL-1? and/or IL-1? and can be used for the treatment immunological diseases such as rheumatoid arthritis, osteoarthritis, psoriasis, multiple sclerosis, and other autoimmune diseases. In addition, their uses in the amelioration and/or treatment of pain in an individual suffering from a disease or disorder associated with IL-1 accumulation.
    Type: Grant
    Filed: July 12, 2013
    Date of Patent: June 6, 2017
    Assignee: AbbVie Inc.
    Inventors: Susan E. Lacy, Lorenzo Benatuil, Meha Chhaya, Emma Fung, Renee Miller, Ravi Chari, Sarah J. Heighton, Jacqueline G. Bixby
  • Anti-NGF antibodies and their use
    Patent number: 9505829
    Abstract: The present disclosure encompasses NGF binding proteins, specifically to antibodies that are chimeric, CDR grafted and canonized antibodies, and methods of making and uses thereof. The antibodies, or antibody portions, of the disclosure are useful for detecting NGF and for inhibiting NGF activity, e.g., in a mammal subject suffering from a disorder in which NGF activity is detrimental.
    Type: Grant
    Filed: August 19, 2011
    Date of Patent: November 29, 2016
    Assignee: ZOETIS BELGIUM S.A.
    Inventors: Susan E. Lacy, Jeffrey A. Barbon, Meha Chhaya, Emma Fung, Charles W. Hutchins, Diane M. Lang, Eve H. Barlow, Mary Leddy, Ravi Chari
  • ANTI-NGF ANTIBODIES AND THEIR USE
    Publication number: 20160264656
    Abstract: The present disclosure encompasses NGF binding proteins, specifically to antibodies that are chimeric, CDR grafted and canonized antibodies, and methods of making and uses thereof. The antibodies, or antibody portions, of the disclosure are useful for detecting NGF and for inhibiting NGF activity, e.g., in a mammal subject suffering from a disorder in which NGF activity is detrimental.
    Type: Application
    Filed: July 14, 2015
    Publication date: September 15, 2016
    Inventors: Susan E. Lacy, Jeffrey A. Barbon, Meha Chhaya, Emma Fung, Charles W. Hutchins, Diane M. Lang, Eve H. Barlow, Mary Leddy, Ravi Chari
  • ANTI-NGF ANTIBODIES AND THEIR USE
    Publication number: 20160002324
    Abstract: The present disclosure encompasses NGF binding proteins, specifically to antibodies that are chimeric, CDR grafted and canonized antibodies, and methods of making and uses thereof. The antibodies, or antibody portions, of the disclosure are useful for detecting NGF and for inhibiting NGF activity, e.g., in a mammal subject suffering from a disorder in which NGF activity is detrimental.
    Type: Application
    Filed: July 13, 2015
    Publication date: January 7, 2016
    Inventors: Susan E. Lacy, Jeffrey A. Barbon, Meha Chhaya, Emma Fung, Charles W. Hutchins, Diane M. Lang, Eve H. Barlow, Mary Leddy, Ravi Chari
  • IL-1 BINDING PROTEINS
    Publication number: 20140178389
    Abstract: The disclosure provides binding proteins that specifically bind to IL-1? and IL-1?. These binding proteins can be organized into DVD-Igs. These proteins can be used to modulate the activity of IL-1? and/or IL-1? and can be used for the treatment immunological diseases such as rheumatoid arthritis, osteoarthritis, psoriasis, multiple sclerosis, and other autoimmune diseases. In addition, their uses in the amelioration and/or treatment of pain in an individual suffering from a disease or disorder associated with IL-1 accumulation.
    Type: Application
    Filed: July 12, 2013
    Publication date: June 26, 2014
    Applicant: ABBVIE, INC.
    Inventors: Susan E. LACY, Lorenzo BENATUIL, Meha CHHAYA, Emma FUNG, Renee MILLER, Ravi CHARI, Sarah J. HEIGHTON, Jacqueline G. BIXBY
  • ANTI-NGF ANTIBODIES AND THEIR USE
    Publication number: 20130330348
    Abstract: The present disclosure encompasses NGF binding proteins, specifically to antibodies that are chimeric, CDR grafted and canonized antibodies, and methods of making and uses thereof. The antibodies, or antibody portions, of the disclosure are useful for detecting NGF and for inhibiting NGF activity, e.g., in a mammal subject suffering from a disorder in which NGF activity is detrimental.
    Type: Application
    Filed: August 19, 2011
    Publication date: December 12, 2013
    Applicant: ABBOTT LABORATORIES
    Inventors: Susan E. Lacy, Jeffrey A. Barbon, Meha Chhaya, Emma Fung, Charles W. Hutchins, Diane M. Lang, Eve H. Barlow, Mary Leddy, Ravi Chari